Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Hematology Hematology for March/April 2020 Most e-consults not followed by specialist visit, Low plasma sodium levels can predict complications in acute painful episodes of SCD, CLL and breast cancer differ in the expression of regulatory microRNAs, More must reads Hematology for January/February 2020 Gene therapy effective in hemophilia B patients with neutralizing antibodies, Fear drives activity changes in hemophilia patients, Deferiprone noninferior to deferoxamine for iron overload in SCD, rare anemias, Occult HCV infection is correlated to unfavorable genotypes in hemophilia patients, Bariatric surgery candidates show high prevalence of thrombophilia, More must readsHematology for November/December 2019 BCL11A-directed gene therapy advances in sickle cell disease, Sutimlimab boosts hemoglobin, quality of life in cold agglutinin disease, NFIX could be a target for sickle cell therapy, Study Halted; ‘Hyperprogression’ Seen With Nivolumab for R/R PTCL, Updated International Consensus Recommendations on Management of Acute Upper GI Bleeding, More must readsHematology for September/October 2019 New Consensus Recommendations on Bleeding in Acquired Hemophilia, Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS, Surveillance for hepatobiliary cancers in primary sclerosing cholangitis, More must readsHematology for July/August 2019 Osteoporotic Fracture Risk Appears Higher in Adults with Hemophilia, RNA Interference Drug Fitusiran Effective in both Hemophilia A and B, Gene Therapy for Hemophilia A Associated With Sustained Reductions in Bleeding Rates, Minor Surgeries Safe for Hemophilia Patients on Emicizumab, No Reduction in PE Risk With Vena Cava Filters After Severe Injury, More must readsPages« first 1 2 3 4 last »
